Literature DB >> 8163762

Improvement of gas exchange following endobronchial instillation of an exogenous surfactant in an infant with respiratory failure by postoperative pulmonary haemorrhage.

K Mikawa1, N Maekawa, K Nishina, O Tanaka, H Yaku, H Obara.   

Abstract

We administered surfactant to a 5-month-old infant with respiratory failure due to right pulmonary haemorrhage accompanied by oedema following abdominal surgery. These pathological conditions were probably precipitated by disseminated intravascular coagulation and intra-operative excessive administration of fluids, respectively. Endobronchial instillation of the exogenous surfactant (120 mg) after selective intubation of the right bronchus produced a dramatic improvement of gas exchange 30 min after treatment and of chest X-ray findings at 6 h post-treatment. This case on an infant indicates that administration of surfactant may be one of promising therapeutic approaches to respiratory failure due to pulmonary haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163762     DOI: 10.1007/bf02425059

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  3 in total

1.  Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.

Authors:  B A Holm; R H Notter
Journal:  J Appl Physiol (1985)       Date:  1987-10

2.  Artificial surfactant therapy in hyaline-membrane disease.

Authors:  T Fujiwara; H Maeta; S Chida; T Morita; Y Watabe; T Abe
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

3.  Surfactant treatment of full-term newborns with respiratory failure.

Authors:  R L Auten; R H Notter; J W Kendig; J M Davis; D L Shapiro
Journal:  Pediatrics       Date:  1991-01       Impact factor: 7.124

  3 in total
  1 in total

1.  Exogenous surfactant therapy for acute respiratory distress in infancy.

Authors:  M Moreno; J Lopez-Herce; C Merello; A Alcaraz; A Carrillo
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.